For nearly 25 years, scientists believed they knew what caused the most severe form of narcolepsy. A new UCLA Health study ...

For nearly 25 years, scientists believed they knew what caused the most severe form of narcolepsy. A new UCLA Health study ...

Alkermes plc ALKS announced the initiation of the phase II Vibrance-2 study, evaluating its novel, investigational, oral orexin 2 receptor agonist ALKS 2680 in adults with narcolepsy type 2 (NT2). The ...

Two new studies to be presented at the SLEEP 2024 annual meeting show that narcolepsy is an independent risk factor for cardiovascular disease and adverse cardiac events. Results show that people who ...

People with certain types of long-term sleep disorders may use a medicine called sodium oxybate to help treat their condition. This medicine is taken at night and may help people with narcolepsy to ...

Could you provide an overview of the Develop hypersomnia Understanding by Evaluating low-sodium oxybate Treatment (DUET) ...

Posters presented at the SLEEP 2023 conference showed that transition between medications was easy but 1 medication felt more effective to patients. Switching from high-sodium oxybate (SXB) to ...

NUTLEY, N.J., March 26, 2026 /PRNewswire/ -- Eisai Inc. announced today that screening for global Study E2086-G000-202 (Study 202) to assess the efficacy, safety and tolerability of E2086, a novel ...

Research indicates a potential link between narcolepsy and schizophrenia, with studies suggesting that individuals with narcolepsy may have a higher risk of developing schizophrenia. Narcolepsy and ...

People with narcolepsy often need to take medicines to manage their symptoms. Many of these medicines carry a high risk for abuse or misuse, so there are restrictions on how they are prescribed and ...

Alkermes ALKS announced positive top-line data from the phase II Vibrance-1 study, which evaluated its novel, investigational, and oral orexin 2 receptor agonist, alixorexton (formerly ALKS 2680), for ...